298 



Index 



Histopathology (Continued) 

 changing morphology, 250 

 coincidental disease, 250, 252 

 complications of diseases, 250 

 criteria of response to therapy, 203-204 

 dominant cell type, 247 

 fibrosis, role of, 245. 248 

 laboratory findings. 251 

 lymphatic leukemia, acute, 225 



chronic, 212-225 

 lymphoma, giant follicular, 204-212 

 lymphosarcoma. 225-231 

 marrow, role of, 248-250 

 monocytic leukemia, 231-232 

 overtreatment, 252 



prior therapy affecting prognosis, 252 

 reticulum cell sarcoma, 246 

 sites of involvement, 250 

 technique, 202-203 

 Hodgkin's disease, 232-246 

 canine malignant lymphoma simulating, 169 

 cytochrome oxidase in, 46 

 enzymes in, 194, 197 

 fibrosis, 245 



after follicular lymphoma, 186 

 granuloma, 236-239 



after follicular lymphoma, terminating as 



acute granulocytic leukemia. 191 

 prognosis, 232, 239 

 transitions in, 182, 236, 239 

 histiocytes of, enzyme activity in, 197. 198 

 histochemistry of lymphocytic tissue in, 194- 



200 

 liver in, 241 

 lymphoma, 205 



after follicular lymphoma. 186 

 enzyme activity in, 197 

 marrow in, 242-245 

 mixed types, 260 

 paragranuloma, 232-236 



prognosis, 232 

 peripheral blood in, 245 

 prognosis, 232, 243 

 response to therapy, 232 

 sarcoma, 239-241 



after Hodgkin's granuloma, 236, 239 

 prognosis, 232, 236 

 spleen in, 242, 215 

 structure of cells in. 262 

 therapy of, 246 

 Hodgkin's tissue in marrow. 2 12. 213 

 Holub, M., 103, 105 

 Homologous transplants. 99 

 Hormone action. See Adrenal gland and hor- 

 mone 

 Horse, lymphocyte count after radiation of, 

 135 

 malignant lymphocytic disease in, 162, 163 

 Hull. R. I... 69 



Hurler's disease, 266 

 Hyaline bodies, appearance of, 118 

 Hyaloplasm, of reticulum cell, 263 

 Hydrolytic enzymes, 194 



Hyperglobulinemia, in lymphocytic leukemia, 

 chronic, 257 

 in lymphoproliferative disorders, 258 

 Hyperhemolysis, in lymphatic leukemia, 



chronic, 219, 222 

 Hyperplasia, erythroblastic, in lymphosarcoma, 

 231 

 of Kupffer cells, in Hodgkin's disease, 241 

 lymph node, after tumor implants, 102 

 germinal center cells in, 15 

 phosphamidase in, 46 

 lymph sinus, and enzyme activity, 195 

 lymphatic, effects on implanted tissue, 100 

 lymphoid, after abdominal irradiation, 139 

 of marrow, in Hodgkin's disease, 243, 245 



in lymphatic leukemia, chronic, 219 

 of myeloid tissue, in follicular lymphoma, 

 209 

 in lymphosarcoma, 231 

 reactive, in leukemia, 177 

 Hypersensitivity, transfer studies of, 103, 107 

 Hypersplenism, dehydrogenase activity in, 45 

 in lymphocytic lymphomas, 249, 250 

 in lymphosarcoma, 231 

 Hyperthyroidism, lymphocytosis in, 149 

 Hypertrophy, of lymphocytes, in inflammation, 

 72, 76, 79 

 of reticulum cell, in Hodgkin's sarcoma, 239 

 Hvpocorticism, adrenal, leukocytoid lym- 

 phocytes in, 282 

 Hypogammaglobulinemia, in lymphocytic leu- 



kema, chronic, 257 

 Hypopituitarism, lymphocytosis in, 149 



Immature lymphocytes. See Prolymphocytes 

 Immunohistochemical studies of antibody sites, 



46, 84 

 Immunologic functions of lymphocytes, 71, 79 

 Immunologic reaction, and tissue transplants, 



100, 106 

 Imprint studies, of blood-forming reticulum 

 cells, 271 

 of cat scratch disease, 264 

 of follicular lymphoma, giant. 278 

 of Hodgkin's disease, 267 

 of Letterer-Siwe's disease, 265, 269 

 of lvmph node preparations, 159, 169 



in enzyme studies, 195, 197 

 of lymphocytic malignant lesions. 262 

 of metastatic tumor cells, 269 

 of mitoses in lymphocytes, 279 

 of plasma cells, 28.5 

 of prolymphocytes, 278 



malignant. 278 

 of reticulum cell sarcoma, 266 



